NCT06719362 2025-07-10A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic TherapiesProvidence Health & ServicesPhase 1 Recruiting110 enrolled